Antiviral Drug Discovery and Development


The Antiviral Drug Discovery and evolution Center (AD3C), organize out of the University of Alabama at Birmingham (UAB) has, at its core, the report to bloom new minuscule particle cures for appearing and re-appearing viral microbes. The fortunate development of antiviral drugs is highly hanging on a close interchange and cooperation linking the chemist and the biologist. This is decorate by a number of typical examples: S-adenosylhomocysteine (SAH) hydrolase restrain which show wide-spectrum antiviral pursuit, bromovinyldeoxyuridine (BVDU) and that are highly mostly inhibitors of varicella-zoster virus (VZV), (dideoxy)nucleoside back transcriptase inhibitors (NRTIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs)



 


    Related Conference of Antiviral Drug Discovery and Development

    April 16-17, 2025

    9th International Conference on Internal Medicine

    Berlin, Germany
    May 12-13, 2025

    19th International Conference on Obesity Medicine

    Toronto, Canada
    June 24-25, 2025

    3rd Global Summit on HIV-AIDS and STDs

    Chicago, USA
    July 21-22, 2025

    24th International Conference on Genomics and Molecular Biology

    Aix-en-Provence, France
    July 21-22, 2025

    11th World Congress on Anesthesia and Critical Care

    Aix-en-Provence, France
    August 07-08, 2025

    12th World Summit on Epilepsy and Bipolar Disorders

    Paris, France
    August 25-26, 2025

    8th International Conference on Community Nursing and Public Health

    Singapore City, Singapore
    September 22-23, 2025

    39th International Conference on Cancer Science & Therapy

    Amsterdam, Netherlands
    October 16-17, 2025

    19th International Conference on Pathology and Laboratory Medicine

    Aix-en-Provence, France
    November 03-04, 2025

    5th World Medicine Congress

    Rome, Italy

    Antiviral Drug Discovery and Development Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in